APPLICATION
ANDA065157
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-12
LATEST ACTION
2025-11-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
PIPERACILLINPrescription
PIPERACILLIN SODIUM EQ 40GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2025-11-06Labeling · Supplement 16 · standardAP
2024-05-01Labeling · Supplement 15 · standardAP
2020-08-04Labeling · Supplement 10 · standardAP
2016-03-05Labeling · Supplement 9 · standardAP
2007-03-02Labeling · Supplement 2AP
2004-07-12OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.